Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCairo University

About this trial

Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.

Eligibility criteria

Qualifiers

critically ill patient mechanically ventilated for 24 hours or more first spontaneous breathing trial

Disqualifiers

patient refusal difficult ultrasound views tracheostomized patient neuromuscular disorders

Trial design

Treatments tested in this trial

  • Parasternal intercostal thickening fraction
  • Sham parasternal intercostal thickening

Treatment groups

200 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Cairo UniversityRecruiting6890, Cairo, Giza GovernorateEgyptEgypt

Sponsors and collaborators